About Us

Fluidx Medical Technology is committed to developing innovative and easy to use medical devices.
The seasoned leadership team at Fluidx is comprised of successful entrepreneurs, well-known interventional physicians, and other proven industry leaders. The team is unified by a commitment to improving patient safety and care through the  development of innovative, easy to use devices. 


Libble Ginster, President & CEO

Libble has over 20 years of business & product leadership experience across life sciences and medtech.  Libble spent more than a decade at Becton Dickinson/ C.R. Bard in leadership roles overseeing multiple businesses, managing corporate strategy/M&A, directing new product development initiatives, as well as leading product commercialization efforts for several high growth businesses.  Earlier in her career, Libble’s experience included marketing and strategy consulting at several early stage companies as well as leading global firms (Merck, Ernst & Young, PricewaterhouseCoopers).  She started her career in investment banking with Lehman Brothers.  She received her Master of Business Administration and Bachelor of Science in Engineering from Duke University.

Chris portrait final - web res.jpg

Christopher Phillips, Director of Regulatory & Clinical Affairs

Chris is a recognized leader with extensive experience in Medical Device Regulatory Affairs, Clinical Affairs, and Quality Assurance. Chris has brought innovative medical devices to market in the USA, Europe, and other global markets for large and small companies including Becton Dickinson, C.R. Bard, Boston Scientific, etc. Chris currently leads Fluidx Medical’s regulatory and clinical efforts, navigating the intersection of these two critical areas. Chris completed a Master of Science degree in Regulatory Affairs from the George Washington University and holds RAPS’ RAC (US) and ASQ’s CBA certifications.

Danny Smith.jpg

Danny Smith, Director of Research & Development

Danny is a veteran R&D professional with over 20 years of experience in medical device design and development. Prior to joining Fluidx, he held R&D leadership positions at both established companies as well as in startup enterprises. His broad experience includes vascular devices, molecular diagnostic systems, and orthopedic products. He specializes in bringing device concepts to market, establishing quality management system processes, and directing team activities. He received his Master of Science in Mechanical Engineering and Bachelor of Science in Mechanical Engineering from Brigham Young University.

Josh Jones - new.jpg

Joshua Jones, PhD, Engineering & Polymer Science

Joshua brings many years of technical experience in materials science and polymer chemistry to Fluidx.  He specializes in biomaterials, synthetic polymers, and polymer-based embolic agents.  He received his Doctor of Philosophy (PhD) in Bioengineering and Biomedical Engineering from the University of Utah and his Bachelor of Science with Honors (BSH) in Chemistry from Berry College.

Russell Stewart.jpg

Russell Stewart, PhD, Co-founder

Russell received his PhD in biochemistry from the University of California, Santa Barbara in 1989. After a postdoctoral fellowship at Harvard University, he worked at the Rowland Institute for Science in Cambridge, MA. In 1994, he joined the faculty of the Department of Bioengineering at the University of Utah. His long standing research interests are in biomimetic engineering. Russell is a Professor in Bioengineering, an Adjunct Professor in Biology, and an Adjunct Professor of Material Science and Engineering at the University of Utah. 

Jessica Karz.jpg

Jessica Karz, Engineering & Polymer Science

Jessica's expertise is centered on polymer science and chemical engineering.  She focuses on polymer and embolic material development and production.  She received her Bachelor of Science in Chemical Engineering from Montana State University.

Shawn Fojtik.jpg

Shawn Fojtik, Co-founder

Shawn is a successful medtech entrepreneur and serial innovator, founding numerous companies including Fluidx Medical, Control Medical, Distal Access, CIRCA Scientific, Pinyons (Covidien), Transit Scientific, Axiom (Teleflex), Occam, and PMT (Mallinckrodt). Earlier in his career, he held product development and commercial leadership roles with GE Medical, Boston Scientific, and Black and Decker. Shawn's clinical experience spans cardiovascular, peripheral vascular, electrophysiology,  interventional oncology, vascular access, etc. He has 75+ issued or pending patents.


Lawrence Kronick, Co-founder

Lawrence has over 35 years of operational and commercial experience in cardiovascular, interventional radiology, electrophysiology, and imaging.  Lawrence is the founder of Business Asia Consultants, Inc., a consulting company with associates in Miami, Sao Paulo, Tokyo, New Delhi, Hong Kong, and Beijing assisting medical device and equipment companies to expand and develop global sales distribution channels. He speaks both Mandarin and English.

Jim McGuckin.jpg

James McGuckin, MD, Co-founder

Dr. McGuckin is Medical Director of the Philadelphia Vascular Institute and is the Founder and CEO of Vascular Access Centers, which specializes in continued function and preservation of dialysis accesses, high-level peripheral arterial work, limb salvage, and venous disorders, including recanalization of central venous occlusion. Dr. McGuckin is also Co-founder and Director of Research at Rex Medical, Chairman of the Board of Endoshape, and a Fellow of the Society of Interventional Radiology.


Ryan O'Hara, MD, Clinical Advisor

Dr. O'Hara is an interventional Radiologist with expertise in vascular embolization techniques. He has served as section chief of Interventional Radiology and Director of Interventional Oncology at the University of Utah and Huntsman Cancer Center respectively. During his tenure he was involved in teaching residents and medical students as well as a class on embolics to students in the department of Bioengineering. In addition, he was involved in research evaluating the use of radioactive microspheres as well as drug-eluting embolics for the treatment of cancer. He currently works as an endovascular specialist with Comprehensive Integrated Care.